For the Quarter Ending September 2025
North America
• In United States, the Oxytetracycline HCL Price Index rose quarter-over-quarter in Q3 2025, driven by increasing production costs.
• Oxytetracycline HCL production costs increased due to a 3.0% CPI rise in September 2025 and 2.6% PPI rise in August 2025.
• Demand outlook for Oxytetracycline HCL was mixed, with strengthening animal healthcare demand in Q3 2025.
• Retail sales increased 5.42% year-over-year in September 2025, supporting demand for animal products.
• US natural gas prices experienced an uptick in Q3 2025, and retail electricity prices increased in September 2025.
• The broader US chemical industry experienced an oversupply situation in Q3 2025, impacting market dynamics.
• Industrial production grew 0.1% year-over-year in September 2025, alongside declining consumer confidence to 94.2.
• Net farm income is projected to increase in 2025, while broiler production increased in Q3 2025.
Why did the price of Oxytetracycline HCL change in September 2025 in North America?
• Production costs rose due to a 3.0% CPI increase in September 2025 and higher energy prices.
• Strong retail sales, up 5.42% year-over-year in September 2025, supported demand for animal products.
• An oversupply in the broader US chemical industry in Q3 2025 exerted downward pressure.
APAC
• In China, the Oxytetracycline HCL Price Index fell in Q3 2025, influenced by weak industrial demand and pricing pressure.
• Oxytetracycline HCL production costs increased in August 2025, driven by higher corn futures and unusually low corn imports.
• The Oxytetracycline HCL demand outlook was challenged in Q3 2025 by slow agricultural product consumption and decreased beef/dairy.
• China's Manufacturing Index contracted in September 2025, indicating a slowdown in industrial activity affecting Oxytetracycline HCL demand.
• Industrial production rose 6.5% year-on-year in September 2025, suggesting robust activity in Oxytetracycline HCL consuming sectors.
• The Producer Price Index (PPI) fell 2.3% year-on-year in September 2025, reflecting weak industrial demand.
• China's chemical industry experienced significant overcapacity in 2025, contributing to downward pressure on Oxytetracycline HCL prices.
• Retail sales grew 3.0% year-on-year in September 2025, supporting consumer demand for animal products and veterinary medicine.
Why did the price of Oxytetracycline HCL change in September 2025 in APAC?
• Weak industrial demand, with PPI falling 2.3% year-on-year, pressured Oxytetracycline HCL prices.
• Contracting Manufacturing Index in September 2025 reduced industrial activity, lowering Oxytetracycline HCL demand.
• Chemical industry overcapacity in China during 2025 contributed to downward Oxytetracycline HCL pricing pressure.
Europe
• In Germany, the Oxytetracycline HCL Price Index fell quarter-over-quarter in Q3 2025, influenced by contracting industrial activity and easing production costs.
• Oxytetracycline HCL production costs eased in Q3 2025, driven by declining hydrochloric acid and moderated ammonium sulfate costs.
• Despite a 2.4% CPI increase in September 2025, producer input costs were influenced by a -1.7% PPI decline.
• Demand for Oxytetracycline HCL faced headwinds in Q3 2025 from a contracting Manufacturing Index and 1.0% industrial production decline.
• Pessimistic consumer confidence at -23.6 in September 2025 indirectly dampened demand for veterinary Oxytetracycline HCL.
• A low 3.9% unemployment rate and 0.8% retail sales growth in September 2025 provided some indirect support.
• Steady growth in the German animal health market in Q3 2025, driven by rising preventive care demand, supported veterinary Oxytetracycline HCL.
• Subdued export performance for Germany's chemical industry in Q3 2025 limited trade opportunities for Oxytetracycline HCL.
Why did the price of Oxytetracycline HCL change in September 2025 in Europe?
• Contracting industrial activity in September 2025, shown by a declining Manufacturing Index, reduced Oxytetracycline HCL demand.
• Producer input costs eased in September 2025, with a -1.7% PPI decline and lower hydrochloric acid prices.
• Pessimistic consumer confidence at -23.6 in September 2025 indirectly dampened Oxytetracycline HCL demand.
For the Quarter Ending June 2023
North America
Oxytetracycline hydrochloride prices fell 3.96% in June compared to levels noticed in April. The price of oxytetracycline hydrochloride has fallen in the United States due to ample supply and weak demand. Market momentum continued to deteriorate due to the erratic supply and demand relationship.
However, weak market activity and lower product supply led to price cuts in the second quarter. China is the largest API exporter to the United States. Due to the ease of trade, oxytetracycline hydrochloride exports to the United States increased, leading to increased supply in the US market, putting downward pressure on prices.
Additionally, inflation slowed in the second quarter as the Federal Reserve raised interest rates, which subsequently reduced demand for oxytetracycline HCl in the US market, resulting in lower prices. In addition, the appreciation of the US dollar against the Chinese yuan in June made US imports cheaper and increased the availability of oxytetracycline hydrochloride, supporting the downtrend. The unfavorable market situation persisted as weak end-user demand forced market traders and suppliers to decrease prices to clear inventory.
Asia Pacific
Oxytetracycline HCl price fell 3.78% in June compared to April. Factors driving this downtrend included ample supply and falling demand both domestically and internationally. The depreciation of the Chinese yuan against the US dollar shows that the momentum of the Chinese economy remains weak, signaling a slowdown in the global economy and increasing pressure on external demand from the consumer sectors. China's manufacturing PMI remained below 50 in the second quarter, with the National Bureau of Statistics (NBS) posting a PMI of 49 in June, down from 48.8 in May and 49.2 in April, indicating a contraction in the manufacturing sector. This slows down production due to weak consumer demand in the healthcare and pharmaceutical sectors, resulting in lower purchasing activity and fewer new orders resulting in lower Oxytetracycline HCl prices. Meanwhile, the war in Ukraine continued to affect the API supply chain, hindering exports to other countries such as the United States, leading to an increase in supply in the Chinese market, and causing a decrease in Oxytetracycline HCl prices.
Europe
Oxytetracycline HCl prices fell 3.99% in June compared to April levels. Factors such as increased purchasing activity and a decline in inventories in the German market contributed to a decline in prices. In Germany, the June 2023 manufacturing PMI (Purchasing Managers Index) fell to 41 from 43.2 in May and 44.5 in April, indicating a collapse in the manufacturing sector due to the impact of the COVID-19 pandemic. Follow-up queries for new orders declined at a faster rate due to weakening end-consumer demand. The German economy has been hit by rising inflation and an interest rate hike by the European Central Bank, leading to higher food and energy prices. This has increased the cost of living, reduced consumer purchasing activity, and supported the downward trend in prices of Oxytetracycline HCl. The appreciation of the Euro against the US dollar makes imports cheaper and also increases the supply of Oxytetracycline HCl in the German market. This puts downward pressure on the price of Oxytetracycline HCl.
For the Quarter Ending March 2023
North America
Prices for Oxytetracycline Hydrochloride showed an upward tendency in North America throughout the first quarter of 2023; however, the last month demonstrated a decremented trend. Prices increased by more than 5% at the beginning of Q1, helped by a large increase in domestic inquiries from the pharmaceutical and healthcare industries. Also, the market has begun to see signs of strength on the China-to-US trade route, which has a positive sign on consumer demand until the mid of the first quarter. While as March approached, the prices of Oxytetracycline Hydrochloride went down at the same rate by which it inclined in February. This was a result of dulled demand, sufficient stockpiles coupled with lower import momentum. With this, the price of Oxytetracycline Hydrochloride ended at USD 22980 /MT in the United States.
Asia
Throughout the first quarter of 2023 in the Asia Pacific region, primarily in China, the Oxytetracycline Hydrochloride prices demonstrate an upsurged trajectory. This price trend was attributed to a significant surge in domestic and international inquiries. Moreover, the market sentiments somewhat improved in China during the holiday-shortened month of January, primarily due to growing demands following the Lunar New Year because both consumption and production increased when the government abandoned its zero-COVID policy. Supply-chain tensions have significantly eased, resulting in better trading activities with overseas countries additionally, kept the market trend on the upper side until February. However, in the month of March, the prices of Oxytetracycline Hydrochloride went down, leading to a rise in inventories among the market participants. With this, the prices were assembled at USD 13300/MT in China.
Europe
In the first quarter of 2023, Oxytetracycline Hydrochloride prices in Europe followed a pattern like those in China. Prices started to gain momentum in early January with an increase in domestic inquiries. Moreover, German consumer prices also rose more than expected in February because of decreasing inflation and declined energy costs, which gradually boosted consumer confidence. Besides this, the market has begun to show signals of strength in support of an improvement in the trade activity from China to Europe in comparison to the previous month. But the prices went down considerably as March approached its end and were settled at USD 24250/MT in Germany.
For the Quarter Ending December 2022
North America
Oxytetracycline Hydrochloride prices in North America oscillated in the fourth quarter of 2022 due to variable demand from the pharmaceutical industry's end-user industries. In the initial two months of Q4 2022, the CFR New York price of Oxytetracycline Hydrochloride increased in the US upto to 5.3% till November end and settled at USD 23560/MT before declining to USD 22460/MT in December. The Golden Week vacation suspended imports, resulting in fewer inventories among US domestic suppliers during the first week of October. As a result, domestic suppliers increased the prices in response to high demand for the product from end-user industries. By the end of the quarter, improvement in import activities from China resulted in sufficient supply in the US domestic market, which caused the cost to be slightly lower. Additionally, the demand from the downstream pharmaceutical industry slowed in December as consumers' interest in purchasing dropped during the year-end season.
Asia- Pacific
Mixed market sentiments were observed in the Asia Pacific region for Oxytetracycline Hydrochloride in Q4 2022. A decrement of 2.9% in price trend was seen in October, with prices settling at USD 13250/MT. During early October, sales for the product marginally declined due to the slowdown in trading activities amidst Golden Week Holiday. After a one-week holiday when the market reopened, the domestic traders faced several contradictory signals, which made it challenging for the participants to keep up with the slow progress witnessed in the downstream industries. At the onset of November, the prices started to increase as the ongoing lockdown measures in some parts of China amid rising COVID-19 cases led to difficulties in production activities. As a consequence, supply shrank, and inventories remained low in the Chinese domestic market. In contrast, demand increased from end-user industries. Therefore, prices remained stable around USD 13450/MT in December due to similar market dynamics as in November.
Europe
Oxytetracycline Hydrochloride had oscillating market dynamics during Europe's fourth quarter of 2022. Oxytetracycline Hydrochloride prices in the German market rose to USD 24200/MT till November as a result of reduced import activity from China over the Golden Week vacation and zero Covid-19 limitations, which resulted in low supplies in the local market. Oxytetracycline Hydrochloride prices, however, tumbled 2.9% in December, settling at USD 23500/MT in Germany owing to declining demand from the downstream pharmaceutical and nutraceutical sectors, which had affected the German market's fundamentals and led to a price reduction. Domestic retailers also had adequate inventory to fulfill demand generally, which led to a downward trend towards the end of the quarter.
